Insmed
INSM
#910
Rank
A$39.13 B
Marketcap
A$178.37
Share price
-1.69%
Change (1 day)
-42.42%
Change (1 year)

EPS for Insmed (INSM)

EPS in 2026 (TTM): A-$4.15

According to Insmed's latest financial reports the company's current EPS (TTM) is A-$4.20. In 2025 the company made an earnings per share (EPS) of A-$9.54 a decrease over its 2024 EPS that were of A-$8.32.

EPS history for Insmed from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$4.15-56.55%
2025A-$9.5414.67%
2024A-$8.32
2022A-$5.810.78%
2021A-$5.7628.57%
2020A-$4.48-0.99%
2019A-$4.53-27.96%
2018A-$6.2847.55%
2017A-$4.260.7%
2016A-$4.2339.9%
2015A-$3.029.73%
2014A-$2.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$7.82-286.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
A-$4.62 9.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$23.33-655.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A-$3.92-6.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.12-73.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A-$1.71-59.22%๐Ÿ‡บ๐Ÿ‡ธ USA